Terug
Dagbereik
€ 6,92
€ 7,26
52-Weeksbereik
€ 2,30
€ 8,60
Volume
139.339
50D / 200D Gem.
€ 7,20
/
€ 4,62
Vorige Slotkoers
€ 7,20
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -14,5 | 0,3 |
| P/B | 8,0 | 2,9 |
| ROE % | -61,0 | 3,7 |
| Net Margin % | — | 3,8 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,2 | 0,2 |
Koersdoel Analisten
Hold
€ 12,00
+71.2%
Forward WPA
-€ 0,50
Omzet Sch.
1,3 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 1,16
€ 0,61 – € 1,98
|
260 M | 1 |
| FY2029 |
-€ 0,02
-€ 0,03 – -€ 0,01
|
91 M | 1 |
| FY2028 |
€ 0,07
€ 0,04 – € 0,13
|
72 M | 1 |
Belangrijkste Punten
Debt/Equity of 0,18 — conservative balance sheet
Negative free cash flow of -32,76M
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-61,00%
ROIC-34,92%
Net MarginN/A
Op. MarginN/A
Veiligheid
Debt / Equity
0,18
Current Ratio7,45
Interest Coverage-100,93
Waardering
P/E Ratio
-14,47
P/B Ratio8,00
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -42,63M |
| ROE | -61,00% | ROA | -40,00% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -32,76M |
| ROIC | -34,92% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,18 | Current Ratio | 7,45 |
| Interest Coverage | -100,93 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -14,47 | P/B Ratio | 8,00 |
| P/S Ratio | N/A | PEG Ratio | -0,53 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 616,95M | Enterprise Value | 614,69M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Net Income | -42,63M | -31,75M | -29,16M | -33,76M | -27,27M |
| EPS (Diluted) | -0,53 | -0,45 | -0,42 | -0,53 | -0,67 |
| Gross Profit | -1,23M | -1,10M | -1,07M | -979.000,0 | -776.000,0 |
| Operating Income | -42,29M | -36,04M | 35,68M | -32,14M | -13,79M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 106,58M | 86,20M | 107,39M | 120,15M | 42,22M |
| Total Liabilities | 29,48M | 23,54M | 22,91M | 14,49M | 76,99M |
| Shareholders' Equity | 77,10M | 62,67M | 84,48M | 105,66M | -34,78M |
| Total Debt | 13,73M | 12,54M | 13,28M | 5,19M | 53,96M |
| Cash & Equivalents | 15,98M | 13,72M | 12,66M | 5,84M | 23,24M |
| Current Assets | 78,30M | 64,23M | 85,76M | 106,48M | 32,64M |
| Current Liabilities | 10,51M | 8,68M | 7,10M | 4,34M | 4,41M |